Novartis
NVS
NVS
1,005 hedge funds and large institutions have $21.1B invested in Novartis in 2017 Q4 according to their latest regulatory filings, with 137 funds opening new positions, 344 increasing their positions, 334 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,005
Holders Change
+69
Holders Change %
+7.37%
% of All Funds
22.83%
Holding in Top 10
24
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-36.84%
% of All Funds
0.55%
New
137
Increased
344
Reduced
334
Closed
63
Calls
$61.9M
Puts
$42.2M
Net Calls
+$19.7M
Net Calls Change
+$526K
Top Buyers
| 1 |
MWNA
1
Marshall Wace North America
New York
|
$120M |
| 2 |
2
Janus Henderson Group
London,
United Kingdom
|
$191M |
| 3 |
3
BlackRock
New York
|
$337M |
| 4 |
4
Morgan Stanley
New York
|
$220M |
| 5 |
5
Renaissance Technologies
New York
|
$144M |
